Innate Immunity to Herpes Simplex Virus Type 2

Viral Immunology

Volumn 16, Issue 4, 2003, Pages 475-490

  Duerst, Rebecca J ^a   Morrison, Lynda A ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CHEMOKINE; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT MEMBRANE ATTACK COMPLEX; GAMMA INTERFERON; INTERFERON;

DISEASE COURSE; GENITAL HERPES; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNE RESPONSE; LATENT PERIOD; NONHUMAN; RECURRENT DISEASE; REVIEW; SEXUALLY TRANSMITTED DISEASE; VIRUS REPLICATION;

DNA VIRUSES; HUMAN HERPESVIRUS 2; SIMPLEXVIRUS;

EID: 0346101551     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/088282403771926300     Document Type: Review

References (122)

1. Al-Khatib, K., B.R. Williams, R.H. Silverman, et al. 2002. Absence of PKR attenuates the anti-HSV-1 activity of an adenoviral vector expressing murine IFN-beta. J. Interferon Cytokine Res. 22:861-871.
2. Albers, I., H. Kirchner, and I. Domke-Opitz. 1989. Resistance of human blood monocytes to infection with herpes simplex virus. Virology 169:466-469.
3. Ashkar, A.A., S. Bauer, W.J. Mitchell, et al. 2003. Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2. J. Virol. 77:8948-8956.
4. Ashkar, A.A., and K.L. Rosenthal. 2003. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J. Virol. 77:10171.
5. Asselin-Paturel, C., A. Boonstra, M. Dalod, et al. 2001. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2:1144-1150.
6. Benencia, F., M.C. Courreges, G. Gamba, et al. 2001. Effect of aminoguanidine, a nitric oxide synthase inhibitor, on ocular infection with herpes simplex virus in Balb/c mice. Invest. Ophthalmol. Vis. Sci. 42:1277-1284.
7. Benencia, F., G. Gamba, H. Cavalieri, et al. 2003. Nitric oxide and HSV vaginal infection in BALB/c mice. Virology 309:75-84.
8. Boutell, C., S. Sadis, and R.D. Everett. 2002. Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro. J. Virol. 76:841-850.
9. Brandt, C.R., and C.A. Salkowski. 1992. Activation of NK cells in mice following corneal infection with herpes simplex virus type-1. Invest. Ophthalmol. Vis. Sci. 33:113-120.
10. Bukowski, J.F., and R.M. Welsh. 1986. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1. J. Immunol. 136:3481-3485.
11. Cassady, K.A., M. Gross, and B. Roizman. 1998. The herpes simplex virus US11 protein effectively compensates for the gamma 1 (34.5) gene if present before activation of protein kinase R by precluding its phosphorylation and that of the alpha subunit of eukaryotic translation initiation factor 2. J. Virol. 72:8620-8626.
12. Cassady, K.A., M. Gross, and B. Roizman. 1998. The second-site mutation in the herpes simplex virus recombinants lacking the gamma 134.5 genes precludes shutoff of protein synthesis by blocking the phosphorylatin of eIF-2alpha. J. Virol. 72:7005-7011.
13. Cayley, P.I., J.A. Davies, K.G. McCullagh, et al. 1984. Acvtivation of the ppp (A2′p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2′p)nA-dependent RNase. Eur. J. Biochem. 143:165-174.
14. Chelbi-Alix M.K.D.H. 1999. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene 18:935-941.
15. Chen, S.H., J.E. Oakes, and R.N. Lausch. 1994. Synergistic anti-herpes effect of TNF-alpha and IFN-gamma in human corneal epithelial cells compared with that in corneal fibroblasts. Antiviral Res. 25:201-213.
16. Confer, D.L., G.M. Vercellotti, D. Kotasek, et al. 1990. Herpes simplex virus-infected cells disarm killer lymphocytes. Proc. Natl. Acad. Sci U. S. A 87:3609-3613.
17. Croen, K.D. 1993. Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J. Clin. Invest. 91:2446-2452.
18. Da Costa, X.J., M.A. Brockman, E. Alicot, et al. 1999. Humoral response to herpes simplex virus is complement-dependent. Proc. Natl. Acad. Sci. U. S. A 96:12708-12712.
19. Deshpande, S.P., U. Kumaraguru, and B.T. Rouse. 2000. Dual role of B cells in mediating innate and acquired immunity to herpes simplex virus infections. Cell. Immunol. 202:79-87.
20. Eidson, K., T. Purohit, and N.A. DeLuca. 2003. Inhibition of phosphorylation and nuclear retention of IRF-3 by HSV-1 ICPO. Presented at the 28th International Herpesvirus Workshop, University of Wisconsin, Madison.
21. Eidson, K.M., W.E. Hobbs, B.J. Manning, et al. 2002. Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection. J. Virol. 76:2180-2191.
22. Eisenberg, R.J., M. Ponce de Leon, H.M. Friedman, et al. 1987. Complement component C3b binds directly to purified glycoprotein C of herpes simplex virus types 1 and 2. Microb. Pathog. 6:423-435.
23. Ellermann-Eriksen, S., J. Justesen, and S.C. Mogensen. 1986. Genetically determined difference in the antiviral action of alpha/beta interferon in cells from mice resistant or susceptible to herpes simplex virus type 2. J. Gen. Virol. 67:1859-1866.
24. Eloranta, M.L., and G.V. Alm. 1999. Splenic marginal metallophilic macrophages and marginal zone macrophages are the major interferon-alpha/beta producers in mice upon intravenous challenge with herpes simplex virus. Scand. J. Immunol. 49:391-394.
25. Eloranta, M.L., K. Sandberg, P. Ricciardi-Castagnoli, et al. 1997. Production of interferon-α/β by murine dendritic cell lines. Scand. J. Immunol. 46:235-241.
26. Everly, D.N., and G.S. Read. 1997. Mutational analysis of the virion host shutoff gene (UL41) of herpes simplex virus (HSV): characterization of HSV type 1 (HSV-1)/HSV-2 chimeras. J. Virol. 71:7157-7166.
27. Everly, D.N., and G.S. Read. 1999. Site-directed mutagenesis of the virion host shutoff gene (UL41) of herpes simplex virus (HSV): analysis of functional differences between HSV type 1 (HSV-1) and HSV-2 alleles. J. Virol. 73:9117-9129.
28. Feduchi, E., M.A. Alonso, and L. Carrasco. 1989. Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus. J. Virol. 63:1354-1359.
29. Feduchi, E., and L. Carrasco. 1991. Mechanism of inhibition of HSV-1 replication by tumor necrosis factor and interferon gamma. Virology 180:822-825.
30. Fenwick, M.L., and R.D. Everett. 1990. Transfer of UL41, the gene controlling virion-associated host cell shut-off, between different strains of herpes simplex virus. J. Gen. Virol. 71:411-418.
31. Finberg, R.W., E.A. Kirk-Jones, J. Zhu, et al. 2003. TLR2 is required for cytokine induction by HSV-1. Presented at the 28th International Herpesvirus Workshop, University of Wisconsin, Madison.
32. Friedman, H.M., G.H. Cohen, R.J. Eisenberg, et al. 1984. Glycoprotein C of herpes simplex virus 1 acts as a receptor for the 3b complement component of infected cells. Nature 309:633-635.
33. Friedman, H.M., J.C. Glorioso, G.H. Cohen, et al. 1986. Binding of complement component C3b to glycoprotein gC of herpes simplex virus type 1: mapping of gC-binding sites and demonstration of conserved C3b binding in low-passage clinical isolates. J. Virol. 60:470-485.
34. Friedman, H.M., L. Wang, N.O. Fishman, et al. 1996. Immune evasion properties of herpes simplex virus type 1 glycoprotein gC. J. Virol. 70:4253-4260.
35. Friedman, H.M., L. Wang, M.K. Pangburn, et al. 2000. Novel mechanism of antibody-independent complement neutralization of herpes simplex virus type 1. J. Immunol. 165:4528-4536.
36. Fries, L.F., H.M. Friedman, G.H. Cohen, et al. 1986. Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade. J. Immunol. 137:1636-1641.
37. Gadjeva, M., A. Verschoor, M.A. Brockman, et al. 2002. Macrophage-derived complement component C4 can restore humoral immunity in C4-deficient mice. J. Immunol. 169:5489-5495.
38. Gangemi, J.D., J. Lazdins, F.M. Dietrich, et al. 1989. Antiviral activity of a novel recombinant human interferon-alpha B/D hybrid. J. Interferon Res. 9:227-237.
39. Gerber, S.I., B.J. Belval, and B.C. Herold. 1995. Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism. Virology 214:29-39.
40. Ghiasi, H., S. Cai, G.C. Perng, et al. 2000. The role of natural killer cells in protection of mice against death and corneal scarring following ocular HSV-1 infection. Antiviral Res. 45:33-45.
41. Gu, H. and B. Roizman. 2003. The degradation of promyelocytic leukemia and Sp100 proteins by herpes simplex virus 1 is mediated by the ubiquitin-conjugating enzyme UbcH5a. Proc. Natl. Acad. Sci. U. S. A 100:8963-8968.
42. Hagglund, R. and B. Roizman. 2002. Characterization of the novel E3 ubiquitin ligase encoded in exon 3 of herpes simplex virus-1-infected cell protein 0. Proc. Natl. Acad. Sci. U. S. A 99:7889-7894.
43. Harandi, A.M., B. Svennerholm, J. Holmgren, et al. 2001. Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity. J. Virol. 75:6705-6709.
44. Harle, P., V. Cull, L. Guo, et al. 2002. Transient transfection of mouse fibroblasts with type I interferon transgenes provides various degrees of protection against herpes simplex virus infection. Antiviral Res. 56:39-49.
45. Harle, P., V.F. Cull, M.P. Agbaga, et al. 2002. Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication. J. Virol. 76:6558-6567.
46. Harle, P.F., S.F. Noisakran, and D.J. Carr. 2001. The application of a plasmid DNA encoding IFN-alpha 1 postinfection enhances cumulative survival of herpes simplex virus type 2 vaginally infected mice. J. Immunol. 166:1803-1812.
47. Harris, S.L., I. Frank, A. Yee, et al. 1990. Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization. J. Infect. Dis. 162:331-337.
48. Hayward, A.R., G.S. Read, and M. Cosyns. 1993. Herpes simplex virus interferes with monocyte accessory cell function. J. Immunol. 150:190-196.
49. He, B., M. Gross, and B. Roizman. 1997. The gamma (1) 34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1 alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci U. S. A. 94:843-848.
50. Heise, M.T. and H.W. Virgin. 1995. The T cell independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J. Virol. 69:904-909.
51. Hendricks, R.L., P.C. Weber, J.L. Taylor, et al. 1991. Endogenously produced interferon alpha protects mice from herpes simplex virus type 1 corneal disease. J. Gen. Virol. 72:1601-1610.
52. Hill, A., P. Jugovic, I. York, et al. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375:411-415.
53. Hill, A.B., B.C. Barnett, A.J. McMichael, et al. 1994. HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2. J. Immunol. 152:2736-2741.
54. Hristova, K., M.E. Selsted, and S.H. White. 1997. Critical role of lipid composition in membrane permeabilization by rabbit neutrophil defensins. J. Biol. Chem. 272:24224-24233.
55. Karupiah, G. and N. Harris. 1995. Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites. J. Exp. Med. 181:2171-2179.
56. Karupiah, G., Q.W. Xie, R.M. Buller, et al. 1993. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 261:1445-1448.
57. Khabar, K.S.A., M. Dhalla, Y. Siddiqui, et al. 2000. Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes. J. Interferon Cytokine Res. 20:653-659.
58. Kleinerman, E.S., R. Snyderman, and C.A. Daniels. 1974. Depression of human monocyte chemotaxis by herpes simplex and influenza viruses. J. Immunol. 113:1562-1567.
59. Klotzbucher, A., S. Mittnacht, H. Kirchner, et al. 1990. Different effects of IFN gamma and IFN alpha/beta on "immediate early" gene expression of HSV-1. Virology 179:487-491.
60. Koff, W.C. and A.V. Fann. 1986. Human tumor necrosis factor-alpha kills herpesvirus-infected but not normal cells. Lymphokine Res. 5:215-221.
61. Kruse, M., O. Rosorius, F. Kratzer, et al. 2000. Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J. Virol. 74:7127-7136.
62. Kunder, S.C., K.M. Kelly, and P.S. Morahan. 1993. Biological response modifier-mediated resistance to herpesvirus infections requires induction of alpha/beta interferon. Antiviral Res. 21:129-139.
63. Kunder, S.C. and P.S. Morahan. 1993. NK cells and interferon as mediators of biological response modifier-mediated protection against MCMV and HSV-2 infection in normal and immunocompromised mice. Ann. N. Y. Acad. Sci. 685:618-619.
64. Kunder, S.C., L. Wu, and P.S. Morahan. 1993. Role of NK cells in immunomodulator-mediated resistance to herpesvirus infection. Antiviral Res. 21:103-118.
65. Lausch, R.N., Y.H. Su, M. Ritchie, et al. 1991. Evidence endogenous interferon production contributed to the lack of ocular virulence of an HSV intertypic recombinant. Curr. Eye Res. 10:39-45.
66. Leary, K., J.R. Connor, and P.S. Morahan. 1985. Comparison of herpes simplex virus type 1 DNA replication and virus production in murine bone marrow-derived and resident peritoneal macrophages. J. Gen. Virol. 66:1123-1129.
67. Leib, D.A., D.M. Coen, C.L. Bogard, et al. 1989. Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J. Virol. 63:759-768.
68. Leib, D.A., T.E. Harrison, K.M. Laslo, et al. 1999. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J. Exp. Med. 189:663-672.
69. Leib, D.A., M.A. Machalek, B.R. Williams, et al. 2000. Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc. Natl. Acad. Sci U. S. A 97:6097-6101.
70. Levy, D.E. and A. Garcia-Sastre. 2001. The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev. 12:143-156.
71. Lin, R., R. Noyce, R. Collins, et al. 2003. The herpes simplex virus ICPO Ring finger domain inhibits IRF3 and IRF7-mediated activation of interferon-stimulated genes. J. Virol. (in press).
72. Lopez, C., D. Kirkpatrick, S.E. Read, et al. 1983. Correlation between low natural killing of fibroblasts infected with herpes simplex virus type 1 and susceptibility to herpesvirus infections. J. Infect. Dis. 147:1030-1035.
73. Lubinski, J., L. Wang, D. Mastellos, et al. 1999. In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC. J. Exp. Med. 190:1637-1646.
74. Lubinski, J.M., M. Jiang, L. Hook, et al. 2002. Herpes simplex virus type 1 evades the effects of antibody and complement in vivo. J. Virol. 76:9232-9241.
75. Lubinski, J.M., L. Wang, A.M. Soulika, et al. 1998. Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo. J. Virol. 72:8257-8263.
76. Lund, J., A. Sato, S. Akira, et al. 2003. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198:513-520.
77. Manickan, E. and B.T. Rouse. 1995. Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse models. J. Virol. 69:8178-8179.
78. Mestan, J., W. Digel, S. Mittnacht, et al. 1986. Antiviral effects of recombinant tumour necrosis factor in vitro. J. Virol. 323:816-819.
79. Mikloska, Z., L. Bosnjak, and A.L. Cunningham. 2001. Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1. J. Virol. 75:5958-5964.
80. Milligan, G., D. Bernstein, and N. Bourne. 1998. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. J. Immunol. 160:6093-6100.
81. Milligan, G.N. 1999. Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2. J. Virol. 73:6380-6386.
82. Milligan, G.N., N. Bourne, and K.L. Dudley. 2001. Role of polymorphonuclear leukocytes in resolution of HSV-2 infection of the mouse vagina. J. Reprod. Immunol. 49:49-65.
83. Mittnacht, S., P. Straub, H. Kirchner, et al. 1988. Interferon treatment inhibits onset of herpes simplex virus immediate-early transcription. Virology 164:201-210.
84. Mossman, K.L., H.A. Saffran, and J.R. Smiley. 2000. Herpes simplex virus ICP0 mutants are hypersensitive to interferon. J. Virol. 74:2052-2056.
85. Murphy, J.A., R.J. Duerst, T.J. Smith, et al. 2003. Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo. J. Virol. 77:9337-9345.
86. Narita, M., Y. Ando, S. Soushi, et al. 1998. The BglII-N fragment of herpes simplex virus type 2 contains a region responsible for resistance to antiviral effects of interferon. J. Gen. Virol. 79:565-572.
87. Noisakran, S., I.L. Campbell, and D.J. Carr. 1999. Ectopic expression of DNA encoding IFN-alpha 1 in the cornea protects mice from herpes simplex virus type 1-induced encephalitis. J. Immunol. 162:4184-4190.
88. Noisakran, S.F., I.L. Campbell, and D.J. Carr. 2000. IFN-alpha1 plasmid construct affords protection against HSV-1 infection in transfected L929 fibroblasts. J. Interfer. Cyto. Res. 20:107-115.
89. Oberman, F. and A. Panet. 1988. Inhibition of transcription of herpes simplex virus immediate early genes in interferon -treated human cells. J. Gen. Virol. 69:1167-1177.
90. Oberman, F., and A. Panet. 1989. Characterization of the early steps of herpes simplex virus replication in interferon-treated human cells. J. Interferon Res. 9:563-571.
91. Oh, S.H., G. Trinchieri, S. Bandyopadhyay, et al. 1990. Natural killer cell-mediated lysis of herpes simplex virus-infected fibroblasts: inability to detect soluble factors that contribute to lysis. Cell Immunol. 127:221-229.
92. Oroskar, A.A., and G.S. Read. 1989. Control of mRNA stability by the virion host shutoff function of herpes simplex virus. J. Virol. 63:1897-1906.
93. Overton, H., D. McMillan, L. Hope, et al. 1994. Production of host shutoff-defective mutants of herpes simplex virus type 1 by inactivation of the UL13 gene. Virology 202:97-106.
94. Parr, E.L., J.J. Bozzola, and M.B. Parr. 1998. Immunity to vaginal infection by herpes simplex virus type 2 in adult mice: Characterization of the immunoglobulins in vaginal mucus. J. Reprod. Immunol. 38:15-30.
95. Parr, M.B., L. Kepple, M.R. McDermott, et al. 1994. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Lab. Invest. 70:369-380.
96. Parr, M.B., L. Kepple, and E.L. Parr. 1991. Antigen recognition in the female reproductive tract. II. Endocytosis of horseradish peroxidase by Langerhans cells in murine vaginal epithelium. Biol. Reprod. 2:261-265.
97. Parr, M.B., and E.L. Parr. 1991. Langerhans cells and T lymphocyte subsets in the murine vagina and cervix. Biol. Reprod. 44:491-498.
98. Pinto, A.J., P.S. Morahan, M. Brinton, et al. 1990. Comparative therapeutic efficacy of recombinant interferons-alpha, -beta, and -gamma against alphatogavirus, bunyavirus, flavivirus, and herpesvirus infections. J. Interferon Res. 10:293-298.
99. Plaeger-Marshall, S., L.A. Wilson, and J.W. Smith. 1983. Alteration of rabbit alveolar and peritoneal macrophage function by herpes simplex virus. Infect. Immun. 41:1376-1379.
100. Poppers, J., M. Mulvey, D. Khoo, et al. 2000. Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Usl 1 protein. J. Virol. 74:11215-11221.
101. Rakasz, E., A. Mueller, S. Perlman, et al. 1999. Gammadelta T cell response induced by vaginal Herpes simplex 2 infection. Immunol. Lett. 70:89-93.
102. Rossol-Voth, R., S. Rossol, K.H. Schutt, et al. 1991. In vivo protective effect of tumour necrosis factor alpha against experimental infection with herpes simplex virus type 1. J. Gen. Virol. 72:143-147.
103. Salio, M., M. Cella, M. Suter, et al. 1999. Inhibition of dendritic cell maturation by herpes simplex virus. Eur. J. Immunol. 29:3245-3253.
104. Schmitt, D.A., H. Sasaki, R.B. Pollard, et al. 1992. Antiviral effects of recombinant human tumor necrosis factor-alpha in combination with natural interferon-beta in mice infected with herpes simplex virus type 1. Antiviral Res. 19:347-352.
105. Schomogyi, M., A. Wald, and J. Corey. 1998. Herpes simplex verus-2 infection. An emerging disease? Infect. Dis. Clin. North. Am. 12:47-61.
106. Shibaki, T., T. Suzutani, I. Yoshida, et al. 2001. Participation of type I interferon in the decreased virulence of the UL13 gene-deleted mutant of herpes simplex virus type I. J. Interfer. Cytokine Res. 21:279-285.
107. Sinha, S., N. Cheshenko, R.I. Lehrer, et al. 2003. NP-1, a rabbit alpha-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2. Antimicrob. Agents Chemother. 47:494-500.
108. Sit, M.F., D.J. Tenney, J.L. Rothstein, et al. 1988. Effect of macrophage activation on resistance of mouse peritoneal macrophages to infection with herpes simplex virus types 1 and 2. J. Gen. Virol. 69:1999-2010.
109. Su, Y.H., J.E. Oakes, and R.N. Lausch. 1990. Ocular avirulence of a herpes simplex virus type 1 strain is associated with heightened sensitivity to alpha/beta interferon. J. Virol. 64:2187-2192.
110. Su, Y.H., J.E. Oakes, and R.N. Lausch. 1993. Mapping the genetic region coding for herpes simplex virus resistance to mouse interferon alpha/beta. J. Gen. Virol. 74:2325-2332.
111. Tal-Singer, R., C. Peng, M. Ponce de Leon, et al. 1995. Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. J. Virol. 69:4471-4483.
112. Taylor, J.L., S.D. Little, and W.J. O'Brien. 1998. The comparative anti-herpes simplex virus effect of human interferons. J. Interfer. Cytok. Res. 18:159-165.
113. + CTL clones recognize HSV-2 infected fibroblasts after treatment with IFN-γ or when virion host shutoff functions are disabled. J. Immunol. 156:3901-3910.
114. Trgovcich, J., D. Johnson, and B. Roizman. 2002. Cell surface major histocompatibility complex class II proteins are regulated by the products of the gamma(1)34.5 and U(L)41 genes of herpes simplex virus 1. J. Virol. 76:6974-6986.
115. Verschoor, A., M.A. Brockman, Knipe D.M., et al. 2001. Cutting edge: myeloid complement C3 enhances the humoral response to peripheral viral infection. J. Immunol. 167:2446-2451.
116. Wong, G.H., and D.V. Goeddel. 1986. Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons. Nature 323:819-822.
117. Wu, L., P.S. Morahan, and K. Leary. 1993. Regulation of herpes simplex virus type 1 gene expression in non-permissive murine resident peritoneal macrophages. J. Leukoc. Biol. 53:61-65.
118. Yokota, S., N. Yokosawa, T. Kubota, et al. 2001. Herpes simplex virus type 1 suppresses the interferon signaling pathway by inhibiting phosphorylation of STATs and janus kinases during an early infection stage. Virology 286:119-124.
119. Zawatzky, R., I. Gresser, E. DeMaeyer, et al. 1982. The role of interferon in the resistance of C57BL/6 mice to various doses of herpes simplex virus type 1. J. Infect. Dis. 146:405-410.
120. Zheng, X., R.H. Silverman, A. Zhou, et al. 2002. Increased severity of HSV-1 keratitis and mortality in mice lacking the 2-5A-dependent RNase L gene. Invest. Ophthalmol. Vis. Sci. 42:120-126.
121. Zhou, A., J.M. Paranjape, S.D. Der, et al. 1999. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology 258:435-440.
122. Zhou, X., E. Deak, K. Soderberg, et al. 2003. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J. Exp. Med. 197:153-162.